Abstract:Background: With the emergence of new influenza virus strains that are resistant to current inhibitors such as oseltamivir (anti-neuraminidase (NA)) and amantadine (anti-M2 proton channel), influenza A viruses continue to be a serious threat to the public health worldwide. With this in view, there is a persistent need for the development of broader and more effective vaccines and therapeutics. Identification of broadly neutralizing antibodies (bNAbs) that recognize relatively invariant structures ‎on influenza haemagglutinin (HA) stem has invigorated efforts to develop universal influenza vaccines. Aim: The current computational study is designed to identify potential flavonoid inhibitors that bind to the contact epitopes of HA stem that are targeted by broadly neutralizing antibodies (bNAb). Method: In this study, we utilized the three-dimensional crystallographic structure of different HA subtypes (H1, H2, H5, H3, and H7) in complex with bNAb to screen for potential broadly reactive influenza inhibitors. We performed Quantitative Structure-Activity and Relationship (QSAR) for 100 natural compounds known for their antiviral activity and performed molecular docking using AutoDock 4.2 suite. Furthermore, we conducted virtual screening of 1413 bioassay hit compounds by using virtual lab bench CLC Drug Discovery. Results: The results showed 18 lead flavonoids with strong binding abilities to bNAb epitopes of various HA subtypes. These 18 broadly reactive compounds exhibited significant interactions with an average of seven Hbonds, docking energy of -22.43 kcal·mol-1, and minimum interaction ‎ energy of -4.65 kcal·mol-1, with functional contact residues. Procyanidin depicted strong interactions with group 1 HAs, whereas both sorbitol and procyanidin exhibited significant interactions with group 2 HAs. Conclusion: Using in silico docking analysis, we identified 18 bioactive flavonoids with potential strong binding cababilities to influenza HA-stems of various subtypes, which are the target for bNAb. The virtual screened bioassay hit compounds depicted a high number of Hbonds but low interaction and docking values compared to antiviral flavonoids. Using structure-based design and nanotechnology-based approaches, identified molecules could be modified to generate next generation anti-influenza drugs.

Citrus-derived flavanones as neuraminidase inhibitors: In vitro and in silico study

Structure-based methoxyflavone derivatives with potent inhibitory activity against various influenza neuraminidases

In Vitro Anti-Viral Activities and Structure-Activity Relationship Studies of Flavones and Dihydroflavone Derivatives As Influenza Virus Potential Neuraminidase Inhibitors

Caffeic Acid Derivatives: A New Type of Influenza Neuraminidase Inhibitors

Design,Synthesis and Anti-influenza Activities of Novel Neuraminidase Inhibitors

Antiviral Activity Of Benzoic Acid Derivative Nc-5 Against Influenza A Virus And Its Neuraminidase Inhibition

Promising Anti-influenza Properties of Active Constituent of Withania Somnifera Ayurvedic Herb in Targeting Neuraminidase of H1N1 Influenza: Computational Study

Discovery of Neuraminidase Inhibitors based on 3D-QSAR, Molecular Docking and MD Simulations

Further Discovery of Caffeic Acid Derivatives As Novel Influenza Neuraminidase Inhibitors

Antiviral Activity of Isoimperatorin Against Influenza A Virus in vitro and its Inhibition of Neuraminidase

Discovery of Acylguanidine Oseltamivir Carboxylate Derivatives As Potent Neuraminidase Inhibitors.

In Vitro Antiviral Effects and 3d Qsar Study of Resveratrol Derivatives As Potent Inhibitors of Influenza H1n1 Neuraminidase

Bioassay of ferulic acid derivatives as influenza neuraminidase inhibitors.

Computational screening of known broad-spectrum antiviral small organic molecules for potential influenza HA stem inhibitors

Optimization of N-Substituted Oseltamivir Derivatives As Potent Inhibitors of Group-1 and -2 Influenza A Neuraminidases, Including a Drug-Resistant Variant.

Anti-influenza A virus activity of flavonoids in vitro: a structure-activity relationship

Combating influenza: natural products as neuraminidase inhibitors

Recent advances in the structure-based design of neuraminidase inhibitors as antiinfluenza agents.

Design, Synthesis and Biological Evaluation of "Multi-Site"-binding Influenza Virus Neuraminidase Inhibitors.

Identification of Chebulinic Acid and Chebulagic Acid as Novel Influenza Viral Neuraminidase Inhibitors

Potent sialic acid inhibitors that target influenza A virus hemagglutinin